CAULI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 208.356
NA - Nord America 15.928
AS - Asia 7.485
SA - Sud America 1.303
Continente sconosciuto - Info sul continente non disponibili 1.031
AF - Africa 205
OC - Oceania 47
Totale 234.355
Nazione #
IT - Italia 203.546
US - Stati Uniti d'America 15.593
SG - Singapore 2.944
CN - Cina 2.276
NL - Olanda 1.159
BR - Brasile 988
UA - Ucraina 763
VN - Vietnam 763
SE - Svezia 692
FI - Finlandia 579
DE - Germania 556
FR - Francia 345
GB - Regno Unito 305
HK - Hong Kong 295
BD - Bangladesh 190
CA - Canada 188
IN - India 188
KR - Corea 151
AR - Argentina 108
JP - Giappone 99
IQ - Iraq 97
TR - Turchia 65
ES - Italia 62
ID - Indonesia 62
PL - Polonia 58
MX - Messico 53
ZA - Sudafrica 50
CO - Colombia 49
EC - Ecuador 47
RU - Federazione Russa 47
AT - Austria 45
AU - Australia 42
PK - Pakistan 40
IR - Iran 32
SA - Arabia Saudita 32
CL - Cile 31
EG - Egitto 29
JO - Giordania 29
PH - Filippine 29
BE - Belgio 28
MA - Marocco 28
UZ - Uzbekistan 28
VE - Venezuela 26
TN - Tunisia 25
CZ - Repubblica Ceca 24
IE - Irlanda 24
IL - Israele 21
JM - Giamaica 20
KE - Kenya 20
MY - Malesia 20
PY - Paraguay 17
GR - Grecia 16
CR - Costa Rica 14
DZ - Algeria 14
LT - Lituania 14
PE - Perù 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
BO - Bolivia 11
CH - Svizzera 11
DK - Danimarca 11
HN - Honduras 11
SN - Senegal 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
PT - Portogallo 9
UY - Uruguay 9
ET - Etiopia 8
NI - Nicaragua 8
NP - Nepal 8
RO - Romania 8
TT - Trinidad e Tobago 8
AL - Albania 7
BG - Bulgaria 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
MD - Moldavia 7
OM - Oman 7
TH - Thailandia 6
GT - Guatemala 5
LB - Libano 5
NO - Norvegia 5
PA - Panama 5
RS - Serbia 5
SI - Slovenia 5
BH - Bahrain 4
BY - Bielorussia 4
GE - Georgia 4
GH - Ghana 4
HR - Croazia 4
LC - Santa Lucia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BJ - Benin 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LK - Sri Lanka 3
PR - Porto Rico 3
Totale 233.282
Città #
Cagliari 195.878
Uta 6.566
Singapore 1.472
Dallas 1.450
Ashburn 1.322
Fairfield 1.224
Amsterdam 1.120
Woodbridge 1.037
San Jose 862
Boardman 727
Houston 676
Chandler 655
Wilmington 535
Council Bluffs 493
Ann Arbor 485
Seattle 446
Beijing 412
Nyköping 410
Jacksonville 407
Cambridge 395
Helsinki 392
Los Angeles 314
Hong Kong 270
Dearborn 243
Santa Clara 228
The Dalles 222
Ho Chi Minh City 219
Lauterbourg 215
Munich 196
Hefei 189
New York 179
Shanghai 171
Boston 164
Nanjing 146
Buffalo 137
Hanoi 135
Seoul 131
Dong Ket 118
Rome 116
Milan 113
San Diego 98
Chicago 88
Columbus 87
São Paulo 86
Toronto 64
London 63
Phoenix 62
Redwood City 62
Tokyo 61
Guangzhou 60
Shenyang 54
Orem 48
Frankfurt am Main 47
Nanchang 47
Nuremberg 47
Redondo Beach 45
Baghdad 44
Brooklyn 40
Hebei 40
Lappeenranta 39
Tianjin 39
Atlanta 35
Denver 35
Da Nang 32
Montreal 31
Rio de Janeiro 31
Belo Horizonte 30
Sassari 30
Warsaw 30
Mountain View 29
Changsha 28
Chennai 28
Jiaxing 28
Tashkent 27
Washington 27
San Francisco 26
Amman 25
Johannesburg 25
Salt Lake City 24
Dhaka 23
Guayaquil 23
Mexico City 23
Mumbai 23
Stockholm 22
Verona 22
Auburn Hills 21
Falls Church 21
Dublin 20
Haiphong 20
Norwalk 20
Turku 20
Brussels 19
Orange 19
Paris 19
Vienna 19
Pune 18
Santiago 18
Detroit 17
Düsseldorf 17
Hangzhou 17
Totale 222.633
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.756
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.189
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.075
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.074
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 3.038
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.909
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.842
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.834
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.812
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.632
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.626
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.625
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.365
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.349
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.348
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.300
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.291
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 2.270
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.266
Polymyalgia rheumatica: an autoinflammatory disorder? 2.247
null 2.245
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.186
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.183
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.180
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.175
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.140
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.117
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.101
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.080
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 2.038
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.993
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.977
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.964
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.960
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.946
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.938
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.924
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.818
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.798
null 1.791
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.705
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 1.677
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.664
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.656
ENDODONTIC RETREATMENT AS AN ALTERNATIVE TO SURGICAL THERAPY IN PATIENTS TREATED WITH BIPHOSPHONATES: A CASE REPORT 1.651
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.646
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.618
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.586
null 1.562
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.502
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.487
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.468
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.463
null 1.431
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.370
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients 1.312
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.270
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.262
Circulating CD8+CD28(null) T cytotoxic cells in polymyositis - a possible biomarker? Comment on the article by Pandya et al. 1.227
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.207
Targeted Therapies in Axial Psoriatic Arthritis 1.188
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 1.148
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) 1.135
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 1.135
null 1.111
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.093
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 1.093
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.080
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.072
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.061
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis 1.032
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 1.011
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.011
Corrigendum to: Exercise Improves the Impact of Chronic Pain in Older Adults: Results of an RCT 1.007
Updated guidelines for the management of axial disease in psoriatic arthritis 1.001
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 998
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 985
Proceedings of the GRAPPA 2016 retreat 963
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 940
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 921
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 920
Whole-body MRI in rheumatology: Major advances and future perspectives 916
Psoriatic disease: Update on traditional disease-modifying antirheumatic drugs 914
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 905
null 902
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 902
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 894
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 886
Exercise Improves the Impact of Chronic Pain in Older Adults: Results of an RCT 881
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 866
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 864
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 863
Familial chilblain and late contractural arachnodactyly: A novel association? 860
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 858
Psoriatic arthritis: genetics and pathogenesis 838
null 831
Asymmetric dimethylarginine: A key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis? 830
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 828
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 823
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 821
Totale 169.553
Categoria #
all - tutte 331.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 331.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.337 0 843 574 484 788 964 619 540 1.266 999 1.719 1.541
2022/202316.853 1.686 2.000 1.566 1.371 1.586 1.753 946 1.576 1.075 1.147 1.349 798
2023/202429.381 1.236 1.193 1.008 1.805 2.640 3.797 3.828 6.340 1.215 1.547 2.585 2.187
2024/202553.103 12.560 12.063 8.696 5.816 2.990 3.003 4.223 328 578 1.595 548 703
2025/202616.137 940 842 2.088 1.469 1.243 1.146 2.734 1.464 1.183 1.362 1.236 430
2026/20271.670 947 723 0 0 0 0 0 0 0 0 0 0
Totale 234.355